In atherosclerosis, anti-inflammatory treatment could also modify the progression of the disease, as shown in recently completed trials that demonstrated the efficacy of IL-1β inhibition on the reduction of cardiovascular risk. The gene discussed is IL1B; the disease is atherosclerosis.